Company: MDCXW
Filing Date: 2025-03-28
Form Type: 253G2
Source: 0001062993-25-006502
Chunk: 156

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-28
Form: 253G2
Chunk 156
---
 the Company (the "Board") will not approve the grant of stock options or other forms of equity based compensation awards to directors or officers during the period of any blackout period.

2.9Canadian Reporting Requirements: Directors and certain officers are required to electronically file insider reports through the System for Electronic Disclosure by Insiders ("SEDI"). Such reports are due within five days of becoming an insider, disclosing such person's beneficial ownership of, or control or direction over, securities of the Company and within five days of the date on which a change in such ownership, or control or direction, occurs. A trade includes the grant of options or the exercise thereof as well as a change in the nature of the ownership, or control or direction over, securities (e.g. a disposition to a company controlled by the insider or a determination that the securities are held in trust for another person). Failure to file a report on time will result in late fees being levied on the insider and may cause future regulatory filings by the Company to be reviewed or cleared on an untimely basis by securities regulators, thereby potentially impairing its access to capital markets.

2.10U.S. Reporting Requirements: From the time the Company is required to report as U.S. Domestic Issuer within the meaning of U.S. securities laws, Section 16(a) of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act"), requires directors, certain officers and 10% beneficial owners of Company securities to file reports with the Securities and Exchange Commission (the "SEC") disclosing their beneficial ownership of Company securities and changes to such beneficial ownership. Changes in beneficial ownership are required to be disclosed on a Form 4 before the end of the second business day following the date of the transaction.Failure to file a report on time may result in fines being imposed by the SEC and the Company and its insiders may be subject to certain consequences for non-compliance with these reporting requirements.

2.11Prior Notification Requirement for Board of Directors and Officers: Directors and officers must provide prior written notice of the intention to carry out a trade (including the exercise of any stock option or any other purchase or sale of any securities of the Company) shall be provided to either the Chief Executive Officer or the Chief Financial Officer the Company. No trade shall be carried out without such notice. Directors and officers are reminded that, notwithstanding such notice, the ultimate responsibility for complying with this Policy and applicable laws and regulations rests with the individual.

2.12Waivers: The Board, at its